Cancer diagnostics firm Epredia and artificial intelligence (AI) software firm Aiforia have entered into a distribution agreement for Aiforia's deep-learning breast cancer image analysis software.
Epredia will distribute Aiforia's Ki67 AI model, which has the CE-IVD Mark, for breast cancer diagnostics in Denmark, France, Germany, Iceland, Italy, Japan, Norway, Spain, Sweden, and the U.S. The software will be part of Epredia's digital pathology portfolio, which already includes its 3DHistech P1000 WSI scanner, the company said.
Aiforia's Ki67 AI model for breast cancer diagnostics. Image courtesy of Aiforia.
